MIR4634

Across TCGA pan-cancer cohorts, MIR4634 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR4634 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR4634 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4634 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

KIRP, UCEC, and STAD are the cancer types where MIR4634 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.479	0.922	<.001	96	view →
UCEC	OS	Tertile	All	0.541	0.877	<.001	78	view →
STAD	DFS	Tertile	All	0.700	0.334	.017	69	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MIR4634–KIRP (DFS)

Open the KIRP breakdown →